Please use this identifier to cite or link to this item:
Title: Early mortality of prostatectomy vs. radiotherapy as a primary treatment for prostate cancer : a population-based study from the United States and East Germany
Author(s): Medenwald, DanielLook up in the Integrated Authority File of the German National Library
Vordermark, DirkLook up in the Integrated Authority File of the German National Library
Dietzel, Christian T.
Issue Date: 2020
Type: Article
Language: English
Abstract: Objective: To assess the extent of early mortality and its temporal course after prostatectomy and radiotherapy in the general population. Methods: Data from the Surveillance, Epidemiology, and End Results (SEER) database and East German epidemiologic cancer registries were used for the years 2005–2013. Metastasized cases were excluded. Analyzing overall mortality, year-specific Cox regression models were used after adjusting for age (including age squared), risk stage, and grading. To estimate temporal hazards, we computed year-specific conditional hazards for surgery and radiotherapy after propensity-score matching and applied piecewise proportional hazard models. Results: In German and US populations, we observed higher initial 3-month mortality odds for prostatectomy (USA: 9.4, 95% CI: 7.8–11.2; Germany: 9.1, 95% CI: 5.1–16.2) approaching the null effect value not before 24-months (estimated annual mean 36-months in US data) after diagnosis. During the observational period, we observed a constant hazard ratio for the 24-month mortality in the US population (2005: 1.7, 95% CI: 1.5–1.9; 2013: 1.9, 95% CI: 1.6–2.2) comparing surgery and radiotherapy. The same was true in the German cohort (2005: 1.4, 95% CI: 0.9–2.1; 2013: 3.3, 95% CI: 2.2–5.1). Considering low-risk cases, the adverse surgery effect appeared stronger. Conclusion: There is strong evidence from two independent populations of a considerably higher early to midterm mortality after prostatectomy compared to radiotherapy extending the time of early mortality considered by previous studies up to 36-months.
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Sponsor/Funder: Publikationsfond MLU
Journal Title: Radiotherapy and oncology
Publisher: Elsevier Science
Publisher Place: Amsterdam [u.a.]
Volume: 9
Issue: 1451
Original Publication: 10.3389/fonc.2019.01451
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
fonc-09-01451.pdf2.68 MBAdobe PDFThumbnail